| I hope that at some point we get to see an in-depth business case study of Pfizer and how they’ve been so successful out of the pandemic. They seem to have an unbelievable grasp of the science-marketing game and how to navigate it successfully at scale. Without getting too far into controversial territory, I’ve observed that - Out of many competing vaccines, Pfizer was always the “cool” one, in both scientific and lay circles - The vaccine has caused a significantly higher number of cardiac side effects than initial studies reported, which has just sort of been swept under the rug - It’s failed to stop the pandemic in any meaningful way And yet - You still won’t read this in most mainstream media, and still can’t mention these things in many social contexts - Governments around the world are still pushing Pfizer/Moderna over all other vaccines (hear about AZ recently?) This article is another example of how their marketing machine is working for them. If I ran a multimillion dollar company in a highly regulated industry, I’d be taking very careful notes of him how Pfizer is playing this one. |
The vaccines also simply work. They worked very well against the wild type where they also prevented infection, and not only drastically reduced death and hospitalisation. They still reduce death and hospitalisation against Omicron. We figured out now that you really want a third dose for best protection, but that is simply something that you can't know if you have to develop a vaccine on such a compressed timescale.
The mRNA vaccines are the best ones against COVID. AZ and J&J have more serious rare side effects, and they are simply less effective. They're still dramatically better than no vaccine, but once the vaccines were not scarce anymore in the developed world, it made sense to focus on the better ones.